evidence: "Running a disinformation campaign against Ivermectin by deliberate suppression of effectiveness of drug Ivermectin as prophylaxis and for treatment of COVID-19, despite the existence of large amounts of clinical data compiled and presented by esteemed, highly qualified, experienced medical doctors and scientists," [...] The notice is based on the research and clinical trials carried out by the ‘Front Line COVID-19 Critical Care Alliance’ (FLCCC) and the British Ivermectin Recommendation Development (BIRD) Panel. These organisations have presented an enormous amount of data that strengthen the case for recommending Ivermectin for the prevention and treatment of COVID-19. [...] However, two key medical bodies, the Indian Council for Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) Delhi, have refused to accept her stand and have retained the recommendation for Ivermectin, under a ‘May Do’ category, for patients with mild symptoms and those in home isolation, as stated in ‘The National Guidelines for COVID-19 management’.